Figure 3: Change in systolic blood pressure (SBP) from baseline, after 8 weeks of treatment, in hypertensive patients treated with different doses of olmesartan (OM), irbesartan (IRB), telmisartan (TEL), valsartan (VAL), all in combination with hydrochlorothiazide (HCTZ) 12.5 or 25 mg. Elaborated from (3).